“INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 31, no. 9, Sept. 2024, pp. 1502-18, https://doi.org/10.53555/68zhqm37.